Claritas Pharmaceuticals Inc V.CLAS.H

This gives me less and less and less confidence

[Captainblk]

I am becoming less and less confident about this all the more I start to dig.

1. outside of Robert, the whole team is a copy and paste from the Salzman Team site:Team - Claritas Pharmaceuticals
2. Team - Salzman (salzmangrp.com) photo and blog pulled right from the page
3. if you go to the History tab on Salzman you can see a series of companies that they have founded.History - Salzman (salzmangrp.com)  googling each one leads you on some interesting paths. some are around, some seem like they've been deadended like what appears is about to happen to KLY:

• inotek is still around, and trading; radikals last press release was 2016;
• Orphan technologies was sold off last year for an appearant 500 million- which begs the question why KLY was to acquire Salzman and not the other way around.(thats the same question I'd have right now with this new company) .
• beetlebung is the earliest mention of kaly, where they seem to have started this shell game by licencing some spinal cord therapy to KLY- that must have been before I got in during the Canniboid/GVHD work I was investing in. 
• the last point in the history thread mentions Herring Creek Pharmaceuticals, which was divested off to a Steady State Inc- both these companies seem to have little to no online existance from a cursory search. thats a bit of concern for me TBH. 

this mild deep dive is causing me some concern, as it looks to be a shell game of companies with non tangible products that are more loose patents than they are concrete medical break throughs. I would love to see some counter arguements, otherwise its a wait and see what NR's come out.

[AngelaL]

I am relatively new to Kalytera so don't know all the history but I certainly know of Salzman. He is a famous scientist and physician - invented a number of major medical breakthroughs at Inotek, Radikal, Orphan, etc. Don't know how Kalytera was able to succeed in getting him on board with a strategic collaboration. I am pretty sure he brought R-107 to Kalytera for Covid. Salzman is the

[Chritters]

Exactly, All he does is bath mouth Kaly I wouldnt take anything he writes with a grain of salt.

[Captainblk]

care to elaborate where he is famous/ what makes him famous? a rudimentary search ( in a couple different search engines) does not turn up much on him- outside of companies he has founded( like some of the ones you quoted) to me thats like saying im famous with these multiple shell companies I made. is he noted in any medical journals or quoted on widely used medical companies for these

[AngelaL]

As a matter of fact I did check. Salzman has published 157 scientific papers. It was easy to find on the web.  https://pubmed.ncbi.nlm.nih.gov/?term=Salzman+al&show_snippets=off&sort=date&size=200      

[Captainblk]

[AngelaL]

Salzman has published in world-class publications if you took the time to read the list. Journals like PNAS, Circulation Research, Journal of Inmunology, Gastroebterokogy, etc. From the bio on the website of his company it's clear he left academia in 1999 so that it is not at all surprising that he didn't publish mich after that. He was the first to develop PARP inhibitors for humans, a

[Captainblk]

so a couple things on this; saying that he was first to develop PARP inhibitors seems to be a wild stretch. his co-contributed paper is referenced along with a few hundred other references on Nature.com article The role of PARP in DNA repair and its therapeutic exploitation: https://www.nature.com/articles/bjc2011382.pdf?origin=ppub click control+F Salz to try and find him There is very

[AngelaL]

To set the record straight: 1. I stated that Salzman was the first to make a human PARP inhibitor, not a prototypic earlier inhibitor. To be the first to create a drug for humans in a novel class is an extraordinary accomplishment. There are maybe less than one hundred people alive in the whole of the USA who have made a first in class drug for all drugs known. 2. PARP inhibitors are now a

[Captainblk]

[AngelaL]

One of the most famous papers from Salzman's laboratory and his company, published in Nature, is cited below. This paper pioneered the concept that PARP activation mediates diabetic vascular dysfunction. This was a breakthrough concept and changed the field. What is striking about his work, and atypical, is the extent of the pioneering concepts introduced by Salzman across so many scientific

[polygraph46]

 Captain:   Looks like the've got academic angelica on board and sipping the Cool Aid over at the Conclave as well.  Please know Captain, that it's exceeding difficult to challenge the misguided. Her gutteral  response with the words  "by the way have you done 1% of what he(Salsman) has done" says it  all  .  kudos to her.......for

[Scotty]

I'd like to add this as well. I personally don't care how effective or revolitionary R-107 is. Salz could make a pill the cures cancer, aids, erectile disfunction, baldness, adds decades to the human life span and makes you shiit gold coins. Looking at KLY's history, there's a near 0% chance it will translate to shareholder value. We'll dilute to fund the research then find a

[ETalien]

I suggest you SELL first thing when unhalted! That way you feel any more this, "less Confidence "! And we don't have to read your drivel...  better for you and better for us!

[Captainblk]

I'll sell once I see $30,000 in my account. Then I'll wish you all luck

[polygraph46]

Captain...mail.